NervGen Pharma Corp. (NGEN)

1.73 -0.02 (-1.14%) USD  |  NASDAQ  |  Oct 09, 16:00
1.73 0.00 (0.00%) After-Hours: 20:00
More

NervGen Pharma EPS Estimates for Next Quarter

EPS Estimates for Next Quarter Chart

View EPS Estimates for Next Quarter for NGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 13, 2026 --
July 14, 2026 --
July 13, 2026 --
May 22, 2026 --
May 21, 2026 --
May 19, 2026 --
May 18, 2026 --
April 28, 2026 --
April 27, 2026 --
April 23, 2026 --
April 15, 2026 --
April 09, 2026 --
Date Value
April 07, 2026 --
April 02, 2026 --
March 31, 2026 --
August 26, 2025 --
July 17, 2025 --
June 02, 2025 --
May 15, 2025 --
April 17, 2025 --
September 09, 2024 --
August 22, 2024 --
August 20, 2024 --
April 30, 2024 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Next Quarter Range, Past 5 Years

View EPS Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Next Quarter Benchmarks

View EPS Estimates for Next Quarter Benchmarks
Start Trial
InMed Pharmaceuticals, Inc. Upgrade
Milestone Pharmaceuticals, Inc. Upgrade
Clearmind Medicine, Inc. --
Lexaria Bioscience Corp. --
Target Group, Inc. (Canada) --

EPS Estimates for Next Quarter Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade